title: [Risperidone and cerebrovascular adverse effects in elderly patients with dementia].
authors.forename: F
authors.initials: F
authors.lastname: Formiga
authors.forename: I
authors.initials: I
authors.lastname: Fort
authors.forename: J M
authors.initials: JM
authors.lastname: Pérez-Castejón
authors.forename: D
authors.initials: D
authors.lastname: Ruiz
authors.forename: E
authors.initials: E
authors.lastname: Duaso
authors.forename: S
authors.initials: S
authors.lastname: Riu
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002561:Cerebrovascular Disorders / Q000209:etiology*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D015140:Dementia, Vascular / Q000188:drug therapy*; D000077265:Donepezil; D005260:Female; D005702:Galantamine / Q000627:therapeutic use; D006801:Humans; D007189:Indans / Q000627:therapeutic use; D008297:Male; D010880:Piperidines / Q000627:therapeutic use; D018967:Risperidone / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D014150:Antipsychotic Agents; D002800:Cholinesterase Inhibitors; D007189:Indans; D010880:Piperidines; D005702:Galantamine; D000077265:Donepezil; D018967:Risperidone